Premier Awards Ultrasound Gel Contract to HR Pharmaceuticals, Inc.
CHARLOTTE, N.C., Dec. 3, 2018 /PRNewswire/ -- Premier has awarded a 36-month group purchasing agreement effective November 1, 2018 for ultrasound gel to York, Pennsylvania based HR Pharmaceuticals, Inc. The new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for ultrasound gel.
EcoVue® was developed as an innovative ultrasound gel that aligns with your sustainable business initiatives. It was designed with not only the patient and physician in mind, but the environment and the role it plays in reducing a carbon footprint. EcoVue's formula and packaging defines the future market and will change the industry's view of ultrasound gel. "With our revolutionary packaging and formula, our non-refillable and single use products will forever change your VUE of ultrasound gel," states Jim Pilsner, HR Pharmaceuticals Director of Marketing. Converting to EcoVue® helps save the environment, reduces gel waste, and increases your bottom line.
Premier is a leading healthcare improvement company, uniting an alliance of approximately 4,000 U.S. hospitals and 165,000 other providers to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and advisory and other services, Premier enables better care and outcomes at a lower cost.
View original content to download multimedia:http://www.prnewswire.com/news-releases/premier-awards-ultrasound-gel-contract-to-hr-pharmaceuticals-inc-300758190.html
SOURCE HR Pharmaceuticals, Inc.